BOSTON, MA / ACCESSWIRE / December 14, 2018 / Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Endo International PLC ("Endo" or the "Company") (ENDP) and certain of its officers and directors violated federal securities laws.
On December 14, 2018, CNBC reported that Endo's shares fell 8 percent on reports of "shocking' data" on opioid distribution. CNBC also released an article titled "The Man Who Took On Big Tobacco Takes Aim At Opioids." According to the article, Endo and other opioid distributors collected data on the amounts and destinations of painkillers as part of a confidential reporting system distributors shared with the Drug Enforcement Agency. A federal judge overseeing many of the lawsuits against opioid makers recently ordered that this data be given to plaintiffs. The data is said to be "shocking," and could play a key role in ongoing litigation resulting from the opioid crisis.
Following the release of this article, the Company's stock fell more than 8 percent.
If you have purchased or otherwise acquired Endo securities and have questions about your legal rights, or possess information relevant to this investigation, you are encouraged to contact attorney Dan DeMariaat (888) 868-2385, by email at firstname.lastname@example.org, or by visiting http://shareholder.law/endo.
Block & Leviton LLP was recently ranked 4th among securities litigation firms by ISS for recoveries in 2017. The firm represents many of the nation's largest institutional investors and numerous individual investors in securities litigation throughout the country. Indeed, its lawyers have recovered billions of dollars for its clients.
This notice may constitute attorney advertising.
BLOCK & LEVITON LLP
(617) 398-5660 phone
155 Federal Street, Suite 400
Boston, MA 02110
SOURCE: Block & Leviton LLP